By targeting αvβ3/α5β1 on tumor-associated CAFs, we observed that the level of CD31-positive vascular cells was significantly reduced, representing an example of an indirect effect of the human-specific BsAb that cannot directly recognize mouse vascular cells. This evidence concerns the gene PECAM1 and neoplasm.